Dermatitis

Risk for Suicidal Ideation, Suicide Attempts Increased in Atopic Dermatitis

Risk for Suicidal Ideation, Suicide Attempts Increased in Atopic Dermatitis

By

Pooling data from 11 of 14 relevant studies, patients with atopic dermatitis were 44% more likely to experience suicidal ideation compared with participants without atopic dermatitis.

Genetics, Clinical Characteristics Tied to Atopic Dermatitis Persistence in Childhood

Genetics, Clinical Characteristics Tied to Atopic Dermatitis Persistence in Childhood

By

The investigators sought to explore heritable, environmental, and clinical factors linked to persistent atopic dermatitis based on 13 years of follow-up in an at-risk birth cohort.

Risk for Depression and Suicidal Ideation Elevated Among Patients With Atopic Dermatitis

Risk for Depression and Suicidal Ideation Elevated Among Patients With Atopic Dermatitis

By

Patients with atopic dermatitis have a higher likelihood of clinical depression and suicidality.

Oral JAK/SYK Inhibitor Granted Fast Track Designation for Atopic Dermatitis

Oral JAK/SYK Inhibitor Granted Fast Track Designation for Atopic Dermatitis

By

The Food and Drug Administration (FDA) has granted Fast Track designation to the investigational oral dual inhibitor, ASN002 (Asana BioSciences), for the treatment of moderate-to-severe atopic dermatitis.

Nickel Sensitivity Rose Significantly in North America From 1994 to 2014

Nickel Sensitivity Rose Significantly in North America From 1994 to 2014

By

Researchers observed that allergic reactions to nickel have significantly increased in the last 20 years.

Oral Food Challenge Failures Frequent in Patients With Atopic Dermatitis

Oral Food Challenge Failures Frequent in Patients With Atopic Dermatitis

By

Investigators examined whether excessive food allergy testing in patients with atopic dermatitis might lead to food intolerance when certain foods are removed from the diet.

Correlation Between Age and Eczema Prevalence Examined

Correlation Between Age and Eczema Prevalence Examined

The mean cumulative lifetime prevalence of atopic eczema is 9.9 percent.

Subcutaneous Dupilumab Initiates Hair Regrowth in Patient With Alopecia Totalis, Atopic Dermatitis

Subcutaneous Dupilumab Initiates Hair Regrowth in Patient With Alopecia Totalis, Atopic Dermatitis

By

Dupilumab, commonly used for eczema, may be effective for hair regrowth in patients with alopecia totalis and atopic dermatitis.

Treatment for Atopic Dermatitis Generally Decreases During Pregnancy

Treatment for Atopic Dermatitis Generally Decreases During Pregnancy

By

Generally, women with AD decreased dermatologic therapy during pregnancy.

Dupilumab Gets Priority Review for Adolescent Atopic Dermatitis

Dupilumab Gets Priority Review for Adolescent Atopic Dermatitis

By

Dupixent is also being assessed in other allergic/inflammatory conditions, including pediatric atopic dermatitis, pediatric asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, grass allergy, and peanut allergy.

Prevalence of Atopic Dermatitis 7.3 Percent in U.S. Adults

Prevalence of Atopic Dermatitis 7.3 Percent in U.S. Adults

The prevalence of atopic dermatitis is 7.3 percent among U.S. adults, and patients with atopic dermatitis and more severe disease have worse quality of life.

Ethnic Variations in Molecular Phenotypes of Patients With Atopic Dermatitis

Ethnic Variations in Molecular Phenotypes of Patients With Atopic Dermatitis

By

Investigators sought to characterize phenotypic variations in patients with atopic dermatitis who were African American and European American.

Improved Systemic, Cutaneous Abnormalities With Dupilumab in Atopic Dermatitis

Improved Systemic, Cutaneous Abnormalities With Dupilumab in Atopic Dermatitis

By

Dupilumab reduced cutaneous and systemic measures of inflammation and improved disease-severity scores in 4 weeks in moderate to severe atopic dermatitis.

Atopic Dermatitis Linked to Depression, Anxiety, and Suicidal Ideation

Atopic Dermatitis Linked to Depression, Anxiety, and Suicidal Ideation

By

Few available studies investigated the risk of completed suicide; however, most of these found a positive correlation between AD and completed suicide.

Early Results Indicate Prolonged Improvements in Atopic Dermatitis With GBR 830

Early Results Indicate Prolonged Improvements in Atopic Dermatitis With GBR 830

By

GBR 830 may be an effective and safe long-term treatment option for patients with moderate to severe atopic dermatitis.

Personal Care Products: What Patients Should Know About Shaving, Detergents, and More

Personal Care Products: What Patients Should Know About Shaving, Detergents, and More

By

Detergents labeled as dye- and fragrance-free may be the best option for certain patients.

Treating Chronic Itch: Therapeutic Review

Treating Chronic Itch: Therapeutic Review

By

Itch is "learned" in the nervous system, said Dr Berger, with involvement by both central and peripheral neural processes.

Use of Bee Venom for Topical Treatment in Patients With Atopic Dermatitis

Use of Bee Venom for Topical Treatment in Patients With Atopic Dermatitis

By

The use of bee venom and its major component, melittin, has proven suitable as an epicutaneous application for the treatment of atopic dermatitis.

Variation of <i>Staphylococcus aureus</i> Clonal Complex Type Linked to Worse Disease Activity in Atopic Dermatitis

Variation of Staphylococcus aureus Clonal Complex Type Linked to Worse Disease Activity in Atopic Dermatitis

By

Of patients who were colonized at both visits, 51.9% remained colonized with the same CC-type at follow-up.

Menthoxypropanediol Provides Itch Relief in Atopic Dermatitis

Menthoxypropanediol Provides Itch Relief in Atopic Dermatitis

The participants were administered a skin care formulation containing menthoxypropanediol.

Atopic Dermatitis Likely Not Associated With Cardiometabolic Disease

Atopic Dermatitis Likely Not Associated With Cardiometabolic Disease

Atopic dermatitis was not found to be an independent risk factor for cardiometabolic disease in this meta-analysis.

Hypersensitivity to Allergens in Personal Care Products More Common in Atopic Dermatitis

Hypersensitivity to Allergens in Personal Care Products More Common in Atopic Dermatitis

By

Polysensitization was reported significantly more often in patients with atopic dermatitis vs those without.

Individuals With Atopic Dermatitis More Likely to Have Antibody Response to <i>S Aureus</i> Superantigens

Individuals With Atopic Dermatitis More Likely to Have Antibody Response to S Aureus Superantigens

An immunoglobulin E (IgE) antibody response to Staphylococcus aureus superantigens is more common among individuals with atopic dermatitis than healthy controls.

Dupilumab Beneficial in Adolescent Patients With Moderate to Severe Atopic Dermatitis

Dupilumab Beneficial in Adolescent Patients With Moderate to Severe Atopic Dermatitis

By

The Phase 3 trial enrolled 251 patients aged 12-17 years old with moderate-to-severe atopic dermatitis, whose disease was not adequately controlled by prescription topical medications or for whom topical treatment was medically inadvisable.

Low Quality of Life, High Disease Burden Seen in Atopic Dermatitis

Low Quality of Life, High Disease Burden Seen in Atopic Dermatitis

By

The study findings support the heavy burden that atopic dermatitis places on patients, particularly those with moderate and severe disease.

Stratum Corneum Samples Effective for Immune Response Analysis in Pediatric Atopic Dermatitis

Stratum Corneum Samples Effective for Immune Response Analysis in Pediatric Atopic Dermatitis

By

Some aspects of pathophysiologic mechanisms may differ in children with atopic dermatitis with light skin types vs those with dark skin types.

Doctors Can Help Children, Teens Adhere to Eczema Treatment Plan

Doctors Can Help Children, Teens Adhere to Eczema Treatment Plan

Physicians can create an adherence protocol for patients, particularly children and teens, receiving treatment for atopic dermatitis.

Nemolizumab Effective for Moderate, Severe Atopic Dermatitis Inadequately Controlled With Topical Therapy

Nemolizumab Effective for Moderate, Severe Atopic Dermatitis Inadequately Controlled With Topical Therapy

By

For patients with moderate to severe atopic dermatitis inadequately controlled with topical therapies, the anti-IL-31 receptor A humanized monoclonal antibody nemolizumab may provide benefit.

Utility of Antimicrobial Textiles Explored for Atopic Dermatitis

Utility of Antimicrobial Textiles Explored for Atopic Dermatitis

By

Functional textiles that rapidly lose their deliverable antimicrobial activity in vitro are not advisable for the AD population.

Atopic Dermatitis Places Heavy Burden on Patients

Atopic Dermatitis Places Heavy Burden on Patients

Atopic dermatitis (AD) dramatically impacts the quality of life of patients.

Sign up for Newsletters